Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2

Anson, B., Mesecar, A., 2020. X-ray structure of SARS-CoV-2 main protease bound to boceprivir at 1.45 Å. PDB ID 6WNP 10. https://10.2210/pdb6WNP/pdb. Baker, D., 1998. Pyran-chromenone compounds, their synthesis and anti-HIV activity. Chikhale, 2021, Computational assessment of saikosaponins as adjuvant treatment for covid-19: molecular docking, dynamics, and network pharmacology analysis, Mol. Divers., 1 Chikhale, 2020, Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach, J. Biomol. Struct. Dyn., 1 Chikhale, 2020, In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19, J. Biomol. Struct. Dyn., 1 De Clercq, 2000, Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection, Med. Res. Rev., 20, 323, 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A El-mekkawy, 1995, Inhibitory effects of egyptian folk medicines oh human immunodeficiency virus (HIV) reverse transcriptase, Chem. Pharm. Bull., 43, 641, 10.1248/cpb.43.641 Consortium, 2004, The Gene Ontology (GO) database and informatics resource, Nucleic Acids Res., 32, D258, 10.1093/nar/gkh036 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Hosseinzade, 2019, Immunomodulatory effects of flavonoids: possible induction of T CD4+ regulatory cells through suppression of mTOR pathway signaling activity, Front. Immunol., 10, 51, 10.3389/fimmu.2019.00051 Johnson, 2012, Ras family of small GTPases in immunity and inflammation, Curr. Opin. Pharmacol., 12, 458, 10.1016/j.coph.2012.02.003 Khanal, 2021, Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19, J. Biomol. Struct. Dyn., 1, 10.1080/07391102.2020.1869588 Khanal, 2021, Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19, RSC Adv., 11, 5065, 10.1039/D0RA10529E Khanal, 2020, Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19 25, J. Ayurveda Int. Med. Kim, 2020, Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2, Protein Sci., 29, 1596, 10.1002/pro.3873 Lan, 2020, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, 581, 215, 10.1038/s41586-020-2180-5 Li, 2005, Identification of natural compounds with antiviral activities against SARS-associated coronavirus, Antivir. Res., 67, 18, 10.1016/j.antiviral.2005.02.007 Li, 2019, WNT/β-catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment, Front. Immunol., 10, 2293, 10.3389/fimmu.2019.02293 Liu, 2009, Anti-coxsackie virus B3 norsesquiterpenoids from the roots of Phyllanthus emblica, J. Nat. Prod., 72, 969, 10.1021/np800792d Lv, 2014, Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway, Antivir. Res., 109, 30, 10.1016/j.antiviral.2014.06.004 Muñoz-Fontela, 2016, Emerging roles of p53 and other tumour-suppressor genes in immune regulation, Nat. Rev. Immunol., 16, 741, 10.1038/nri.2016.99 Palazon, 2014, HIF transcription factors, inflammation, and immunity, Immunity, 41, 518, 10.1016/j.immuni.2014.09.008 Park, 2008, Chromone and chromanone derivatives as strand transfer inhibitors of HIV-1 integrase, Arch. Pharm. Res., 31, 1, 10.1007/s12272-008-1111-z Patil, 2020, Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in Covid-19, Inform. Med. Unlocked Šedý, 2014, Tumor necrosis factor superfamily in innate immunity and inflammation, Cold Spring Harb. Perspect. Biol., 7 Shannon, 2003, Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res., 13, 2498, 10.1101/gr.1239303 Variya, 2016, Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms, Pharmacol. Res., 111, 180, 10.1016/j.phrs.2016.06.013 Xiang, 2010, Effects of 1, 2, 4, 6-tetra-O-galloyl-β-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2. 2.15 cell culture, Virol. Sin., 25, 375, 10.1007/s12250-010-3144-y Xiang, 2011, In vitro anti-herpes simplex virus activity of 1, 2, 4, 6-Tetra-O-galloyl-β-D-glucose from Phyllanthus emblica L.(Euphorbiaceae), Phytother. Res., 25, 975, 10.1002/ptr.3368 Zenobia, 2015, Basic biology and role of interleukin-17 in immunity and inflammation, Periodontol, 69, 142, 10.1111/prd.12083